Preliminary estimation of the prevalence of chemotherapy-induced dysgeusia in Japanese patients with cancer

Por Imai, Hiroo, Soeda, Hiroshi, Komine, Keigo, Otsuka, Kazunori, Shibata, Hiroyuki
Publicado em 2013

Functional Complementation Assay for 47 MUTYH Variants in a MutY-Disrupted Escherichia Coli Strain

Por Komine, Keigo, Shimodaira, Hideki, Takao, Masashi, Soeda, Hiroshi, Zhang, Xiaofei, Takahashi, Masanobu, Ishioka, Chikashi
Publicado no Hum Mutat (2015)

KRAS mutation in patients with metastatic colorectal cancer does not preclude benefit from oxaliplatin-or irinotecan-based treatment

Por SOEDA, HIROSHI, SHIMODAIRA, HIDEKI, WATANABE, MIKA, SUZUKI, TAKAO, GAMO, MAKIO, TAKAHASHI, MASANOBU, KOMINE, KEIGO, KATO, SHUNSUKE, ISHIOKA, CHIKASHI
Publicado em 2014

Efficacy and safety of gemcitabine plus docetaxel in Japanese patients with unresectable or recurrent bone and soft tissue sarcoma: Results from a single-institutional analysis

Por Takahashi, Masanobu, Komine, Keigo, Imai, Hiroo, Okada, Yoshinari, Saijo, Ken, Takahashi, Masahiro, Shirota, Hidekazu, Ohori, Hisatsugu, Takahashi, Shin, Chiba, Natsuko, Mori, Takahiro, Shimodaira, Hideki, Ishioka, Chikashi
Publicado no PLoS One (2017)

The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study

Por Takahashi, Masahiro, Takahashi, Masanobu, Komine, Keigo, Yamada, Hideharu, Kasahara, Yuki, Chikamatsu, Sonoko, Okita, Akira, Ito, Shukuei, Ouchi, Kota, Okada, Yoshinari, Imai, Hiroo, Saijo, Ken, Shirota, Hidekazu, Takahashi, Shin, Mori, Takahiro, Shimodaira, Hideki, Ishioka, Chikashi
Publicado no PLoS One (2017)